Evidence map›Paper›PMID 33893449›Full record

ArticleEuropean journal of clinical nutrition2021

Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study.

Antonio Julià, Sergio H Martínez-Mateu, Eugeni Domènech, Juan D Cañete, Carlos Ferrándiz, Jesús Tornero, Javier P Gisbert, Antonio Fernández-Nebro, Esteban Daudén, Manuel Barreiro-de Acosta and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 2 countries.

Antonio JuliàRheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain. toni.julia@vhir.org.ORCID http://orcid.org/0000-0001-6064-3620
Sergio H Martínez-MateuRheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6656-3231
Eugeni DomènechHospital Universitari Germans Trias i Pujol, Badalona, Spain.
Juan D CañeteHospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain.
Carlos FerrándizHospital Universitari Germans Trias i Pujol, Badalona, Spain.
Jesús TorneroHospital Universitario de Guadalajara, Guadalajara, Spain.
Javier P GisbertCIBERehd, Madrid, Spain.
Antonio Fernández-NebroUGC Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain.
Esteban DaudénHospital Universitario de La Princesa and IIS-IP, Madrid, Spain.
Manuel Barreiro-de AcostaHospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Carolina PérezHospital del Mar, Barcelona, Spain.
Rubén QueiróHospital Universitario Central de Asturias, Oviedo, Spain.ORCID http://orcid.org/0000-0002-8418-7145
Francisco Javier López-LongoHospital General Universitario Gregorio Marañón, Madrid, Spain.
José Luís Sánchez CarazoConsorcio Hospital General Universitario de Valencia, Valencia, Spain.
Juan Luís MendozaHospital Clínico San Carlos, Madrid, Spain.
Mercedes AlpériHospital Universitario Central de Asturias, Oviedo, Spain.
Carlos MontillaHospital Virgen de la Vega, Salamanca, Spain.
José Javier Pérez VenegasHospital Universitario Virgen Macarena, Sevilla, Spain.
Fernando MuñozComplejo Asistencial Universitario de León, León, Spain.
Santos CastañedaHospital Universitario de La Princesa and IIS-IP, Madrid, Spain.
Adrià AteridoRheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain.
María López LasantaRheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain.
Sara MarsalRheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain. sara.marsal@vhir.org.ORCID http://orcid.org/0000-0001-5515-3854
IMID Consortium
Vall d'Hebron Hospital Universitari · ESComplexo Hospitalario Universitario A Coruña · ESHospital de Sant Pau · ESHospital Universitario de La Princesa · ESHospital Universitario 12 De Octubre · ESBellvitge University Hospital · ESComplejo Asistencial Universitario de Palencia · ESComplejo Hospitalario de Salamanca · ESComplejo Hospitalario Universitario de Santiago · ESFundació Clínic per a la Recerca Biomèdica · ESHospital Clínic de Barcelona · ESHospital Clínico San Carlos · ESHospital General Universitario de Alicante Doctor Balmis · ESHospital General Universitario Gregorio Marañón · ESHospital Universitari Germans Trias i Pujol · ESHospital Universitario Central de Asturias · ESHospital Universitario Fundación Alcorcón · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Reina Sofía · ESHospital Universitario Virgen Macarena · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesImmune-mediated inflammatory diseases (IMIDs) are prevalent diseases. There is, however, a lack of understanding of the link between diet and IMIDs, how much dietary patterns vary between them and if there are food groups associated with a worsening of the disease. SUBJECTS/

methodsTo answer these questions we analyzed a nation-wide cohort of n = 11,308 patients from six prevalent IMIDs and 2050 healthy controls. We compared their weekly intake of the major food categories, and used a Mendelian randomization approach to determine which dietary changes are caused by disease. Within each IMID, we analyzed the association between food frequency and disease severity.

resultsAfter quality control, n = 11,230 recruited individuals were used in this study. We found that diet is profoundly altered in all IMIDs: at least three food categories are significantly altered in each disease (P < 0.05). Inflammatory bowel diseases showed the largest differences compared to controls (n ≥ 8 categories, P < 0.05). Mendelian randomization analysis supported that some of these dietary changes, like vegetable reduction in Crohn's Disease (P = 2.5 × 10

conclusionsThis cross-disease study demonstrates that prevalent IMIDs are associated to a significant change in the normal dietary patterns. This variation is highly disease-specific and, in some cases, it is caused by the disease itself. Severity in IMIDs is also associated with specific food groups. The results of this study underscore the importance of studying diet in IMIDs.

Indexed as

Crohn DiseaseInflammatory Bowel DiseasesLupus Erythematosus, SystemicHumansMendelian Randomization AnalysisSeverity of Illness Index

Identifiers

PMID33893449
OpenAlexW3155814584

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.